Literature DB >> 1525555

Potential oxyradical damage and energy status in individual muscle fibres from degenerating muscle diseases.

L Austin1, M de Niese, A McGregor, H Arthur, A Gurusinghe, M K Gould.   

Abstract

Inherited degenerating muscle diseases result in disintegration of muscle fibres, which is initiated by a lack of or alteration to a muscle protein. In Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) the protein is known to be dystrophin. The cellular function of dystrophin is not known in any detail but its absence appears to lead to a weakening of the sarcolemma. It has been proposed by Murphy and Kehrer that this leads ultimately to increased oxyradical production which may accelerate the degeneration. Studies have been carried out on individual muscle fibres derived from biopsy samples from patients with a number of degenerative muscle diseases. The glutathione cycling components, in particular glutathione and glutathione peroxidase, are significantly elevated in DMD, BMD and other diseases. Glutathione reductase is also elevated in some of these diseases. Energy producing systems are also affected particularly in intact fibres of muscle derived from muscle at an advanced stage of the disease. These results suggest that oxyradical damage may occur as a secondary consequence of muscle degenerating disease, leading to a breakdown in the glycogenolytic energy producing system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525555     DOI: 10.1016/0960-8966(92)90023-y

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

1.  Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.

Authors:  Sonia Messina; Domenica Altavilla; M'hammed Aguennouz; Paolo Seminara; Letteria Minutoli; Maria C Monici; Alessandra Bitto; Anna Mazzeo; Herbert Marini; Francesco Squadrito; Giuseppe Vita
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

2.  Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource.

Authors:  Lara Khouzami; Marie-Claude Bourin; Christo Christov; Thibaud Damy; Brigitte Escoubet; Philippe Caramelle; Magali Perier; Karim Wahbi; Christophe Meune; Catherine Pavoine; Françoise Pecker
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

3.  Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers.

Authors:  Vyacheslav M Shkryl; Adriano S Martins; Nina D Ullrich; Martha C Nowycky; Ernst Niggli; Natalia Shirokova
Journal:  Pflugers Arch       Date:  2009-04-22       Impact factor: 3.657

Review 4.  Markers of oxidative stress and aging in Duchene muscular dystrophy patients and the possible ameliorating effect of He:Ne laser.

Authors:  Salam E Abdel; I Abdel-Meguid; S Korraa
Journal:  Acta Myol       Date:  2007-07

5.  Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency.

Authors:  Emma Rybalka; Cara A Timpani; Matthew B Cooke; Andrew D Williams; Alan Hayes
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 6.  Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.

Authors:  Cara A Timpani; Alan Hayes; Emma Rybalka
Journal:  Orphanet J Rare Dis       Date:  2017-05-25       Impact factor: 4.123

7.  Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.

Authors:  Cara A Timpani; Adam J Trewin; Vanesa Stojanovska; Ainsley Robinson; Craig A Goodman; Kulmira Nurgali; Andrew C Betik; Nigel Stepto; Alan Hayes; Glenn K McConell; Emma Rybalka
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 8.  Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy.

Authors:  Emma Rybalka; Cara A Timpani; Christos G Stathis; Alan Hayes; Matthew B Cooke
Journal:  Nutrients       Date:  2015-11-26       Impact factor: 5.717

9.  Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.

Authors:  Candice Brinkmeyer-Langford; Candice Chu; Cynthia Balog-Alvarez; Xue Yu; James J Cai; Mary Nabity; Joe N Kornegay
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

10.  Elevated GLUT4 and glycogenin protein abundance correspond to increased glycogen content in the soleus muscle of mdx mice with no benefit associated with taurine supplementation.

Authors:  Robert G Barker; Barnaby P Frankish; Hongyang Xu; Robyn M Murphy
Journal:  Physiol Rep       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.